C07C 217/06
Having only one etherified hydroxy group and one amino group bound to
Official title: having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
C07C217/06 (Having only one etherified hydroxy group and one amino group bound to) appears on 818 US grants and 741 published applications in this corpus.
Search patents in C07C- Granted patents
- 818
- Published applications
- 741
- Assignees
- 512
- Inventors
- 2,242
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 14 | 0 |
| 1990 | 5 | 0 |
| 1991 | 21 | 0 |
| 1992 | 16 | 0 |
| 1993 | 17 | 0 |
| 1994 | 14 | 0 |
| 1995 | 24 | 0 |
| 1996 | 21 | 0 |
| 1997 | 25 | 0 |
| 1998 | 20 | 0 |
| 1999 | 17 | 0 |
| 2000 | 23 | 0 |
| 2001 | 23 | 6 |
| 2002 | 23 | 19 |
| 2003 | 17 | 25 |
| 2004 | 15 | 45 |
| 2005 | 19 | 32 |
| 2006 | 28 | 39 |
| 2007 | 20 | 19 |
| 2008 | 32 | 34 |
| 2009 | 18 | 25 |
| 2010 | 18 | 25 |
| 2011 | 14 | 32 |
| 2012 | 25 | 29 |
| 2013 | 23 | 42 |
| 2014 | 38 | 34 |
| 2015 | 33 | 46 |
| 2016 | 43 | 37 |
| 2017 | 31 | 32 |
| 2018 | 20 | 28 |
| 2019 | 19 | 23 |
| 2020 | 17 | 28 |
| 2021 | 24 | 23 |
| 2022 | 21 | 33 |
| 2023 | 20 | 20 |
| 2024 | 18 | 32 |
| 2025 | 15 | 19 |
| 2026 | 11 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nitrogen-branched non-linear pegylated lipid containing a tertiary amine and application thereof18 Aug 2026US 12,708,675 B2Xiamen Sinopeg Biotech Co., Ltd.
- Compound, cellular vesicle staining agent, and method of fluorescent staining for cellular vesicles11 Aug 2026US 12,704,443 B2National University Corporation Tokai National Higher Education and Research System
- Valiolamine derivatives as glucosidase inhibitors7 Jul 2026US 12,673,924 B2Emergent Product Development Gaithersburg Inc.
- Cosmetic salts9 Jun 2026US 12,648,899 B2Tara Brands Europe S.L.U.
- Functionalized thermoplastic polyurethane, method for producing same, method for producing highly functional medical composite material using same, and medical device including same19 May 2026US 12,630,665 B2I-Sens, Inc.
- Methods for making and using endoxifen24 Sep 2026US 2026/0285798 A1Atossa Therapeutics, Inc.
- Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents17 Sep 2026US 2026/0274784 A1ModernaTX, Inc.
- Functionalized thermoplastic polyurethane, method for producing same, method for producing highly functional medical composite material using same, and medical device including same20 Aug 2026US 2026/0242532 A1I-Sens, Inc.
- Amino lipid compound, and preparation method therefor and use thereof30 Jul 2026US 2026/0217645 A1Shenzhen Shenxin Biotechnology Co., Ltd.
- Surfactant compositions derived from waste streams, and methods30 Jul 2026US 2026/0218053 A1Kemira Oyj
Most cited
By later US patents
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- Aminoalcohol lipidoids and uses thereof207US 8,450,298 B2Massachusetts Institute of Technology · 2013
- High molecular weight polymer-based prodrugs182US 5,614,549 AEnzon, Inc. · 1997
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000